|
GNA13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.26220000013144E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.78149999996435E-06 |
| Normal-vs-Stage2 |
2.87470000026602E-07 |
| Normal-vs-Stage3 |
1.47409999984305E-07 |
| Normal-vs-Stage4 |
1.0181999998693E-07 |
| Stage1-vs-Stage2 |
1.852160E-01 |
| Stage1-vs-Stage3 |
9.325800E-02 |
| Stage1-vs-Stage4 |
6.400000E-02 |
| Stage2-vs-Stage3 |
9.639000E-01 |
| Stage2-vs-Stage4 |
6.679400E-01 |
| Stage3-vs-Stage4 |
6.159400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.75370000030395E-07 |
| Normal-vs-AfricanAmerican |
5.62779999999652E-05 |
| Normal-vs-Asian |
8.12420000051439E-07 |
| Caucasian-vs-AfricanAmerican |
6.488000E-01 |
| Caucasian-vs-Asian |
7.358400E-01 |
| AfricanAmerican-vs-Asian |
4.679600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.91110000000461E-07 |
| Normal-vs-Female |
4.2215999995765E-07 |
| Male-vs-Female |
6.714400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.92934999999617E-05 |
| Normal-vs-Age(41-60Yrs) |
4.53730000238295E-08 |
| Normal-vs-Age(61-80Yrs) |
1.28149999945038E-07 |
| Normal-vs-Age(81-100Yrs) |
7.778100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.155600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.843800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.294800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.953000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.431200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.637000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.654800E-01 |
| Classical-VS-Follicular |
5.563800E-02 |
| Classical-VS-Other |
2.618800E-01 |
| Classical-VS-Normal |
2.61310000004844E-06 |
| Tall-VS-Follicular |
9.227200E-01 |
| Tall-VS-Other |
6.147400E-01 |
| Tall-VS-Normal |
3.60909999996828E-06 |
| Follicular-VS-Other |
6.196200E-01 |
| Follicular-VS-Normal |
1.54630000026579E-07 |
| Other-VS-Normal |
1.026020E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.22760000129819E-08 |
| Normal-vs-N1 |
5.01439999522901E-08 |
| N0-vs-N1 |
4.256400E-01 |
|
|
